• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从一名因AIPL1基因突变导致莱伯先天性黑蒙的患者身上生成人诱导多能干细胞系。

Generation of a human iPSC line from a patient with Leber congenital amaurosis caused by mutation in AIPL1.

作者信息

Lukovic Dunja, Artero Castro Ana, León Marian, Del Buey Furió Verónica, Cortón Marta, Ayuso Carmen, Erceg Slaven

机构信息

National Stem Cell Bank-Valencia Node, Proteomics, Genotyping and Cell Line Platform, PRB3, ISCIII, Research Centre Principe Felipe, c/ Eduardo Primo Yúfera 3, Valencia 46012, Spain.

National Stem Cell Bank-Valencia Node, Proteomics, Genotyping and Cell Line Platform, PRB3, ISCIII, Research Centre Principe Felipe, c/ Eduardo Primo Yúfera 3, Valencia 46012, Spain.

出版信息

Stem Cell Res. 2018 Dec;33:151-155. doi: 10.1016/j.scr.2018.10.012. Epub 2018 Oct 5.

DOI:10.1016/j.scr.2018.10.012
PMID:30366342
Abstract

The human induced pluripotent stem cell (hiPSC) line, derived from dermal fibroblasts from Leber congenital amaurosis patient with homozygous mutation c.265 T > C, p.Cys89Arg in aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1) was generated by Sendai virus reprogramming. The generated hiPSC line was free of Sendai virus genes, had stable karyotype, carried the homozygous mutation, was immunopositive to pluripotency markers and able to generate all three germ layers upon embryoid body formation. Resource table.

摘要

通过仙台病毒重编程,从患有纯合突变c.265T>C、p.Cys89Arg的芳基烃受体相互作用蛋白样1(AIPL1)基因的莱伯先天性黑蒙患者的皮肤成纤维细胞中获得了人诱导多能干细胞(hiPSC)系。所产生的hiPSC系不含仙台病毒基因,具有稳定的核型,携带纯合突变,对多能性标志物呈免疫阳性,并且在形成胚状体时能够产生所有三个胚层。资源表。

相似文献

1
Generation of a human iPSC line from a patient with Leber congenital amaurosis caused by mutation in AIPL1.从一名因AIPL1基因突变导致莱伯先天性黑蒙的患者身上生成人诱导多能干细胞系。
Stem Cell Res. 2018 Dec;33:151-155. doi: 10.1016/j.scr.2018.10.012. Epub 2018 Oct 5.
2
Retinal Organoids derived from hiPSCs of an AIPL1-LCA Patient Maintain Cytoarchitecture despite Reduced levels of Mutant AIPL1.源自 AIPL1-LCA 患者 hiPSC 的视网膜类器官在降低突变 AIPL1 水平的情况下仍保持细胞结构。
Sci Rep. 2020 Mar 25;10(1):5426. doi: 10.1038/s41598-020-62047-2.
3
Generation of Leber congenital amaurosis, type 12 patient-specific induced pluripotent stem cell line (LVPEIi006-A), harboring a homozygous mutation in RD3.12 型莱伯先天性黑蒙症患者特异性诱导多能干细胞系(LVPEIi006-A)的建立,该细胞系携带 RD3 基因的纯合突变。
Stem Cell Res. 2024 Jun;77:103380. doi: 10.1016/j.scr.2024.103380. Epub 2024 Mar 10.
4
Generation of a human iPSC line, INMi004-A, with a point mutation in CRX associated with autosomal dominant Leber congenital amaurosis.生成携带与常染色体显性遗传性莱伯先天性黑蒙相关的CRX基因点突变的人诱导多能干细胞系INMi004-A。
Stem Cell Res. 2019 Jul;38:101476. doi: 10.1016/j.scr.2019.101476. Epub 2019 Jun 3.
5
Generation of a human induced pluripotent stem cell line from a patient with Leber congenital amaurosis.从一位莱伯先天性黑蒙症患者中诱导生成人多能干细胞系。
Stem Cell Res. 2020 Mar;43:101725. doi: 10.1016/j.scr.2020.101725. Epub 2020 Jan 29.
6
Genome-wide homozygosity mapping in families with leber congenital amaurosis identifies mutations in AIPL1 and RDH12 genes.对患有莱伯先天性黑蒙的家族进行全基因组纯合性定位,确定了AIPL1和RDH12基因中的突变。
DNA Cell Biol. 2014 Dec;33(12):876-83. doi: 10.1089/dna.2014.2554.
7
Residual electroretinograms in young Leber congenital amaurosis patients with mutations of AIPL1.年轻莱伯先天性黑矇患者 AIPL1 基因突变的残余视网膜电图。
Invest Ophthalmol Vis Sci. 2011 Oct 17;52(11):8166-73. doi: 10.1167/iovs.11-8298.
8
Gene and Cell Therapy for AIPL1-Associated Leber Congenital Amaurosis: Challenges and Prospects.AIPL1 相关先天性黑矇性眼病的基因和细胞治疗:挑战与展望。
Adv Exp Med Biol. 2019;1185:97-101. doi: 10.1007/978-3-030-27378-1_16.
9
Investigation of PTC124-mediated translational readthrough in a retinal organoid model of AIPL1-associated Leber congenital amaurosis.在 AIPL1 相关莱伯先天性黑矇的视网膜类器官模型中研究 PTC124 介导的翻译通读。
Stem Cell Reports. 2022 Oct 11;17(10):2187-2202. doi: 10.1016/j.stemcr.2022.08.005. Epub 2022 Sep 8.
10
Generation of two induced pluripotent stem cell lines (LVPEIi004-A and LVPEIi005-A) from probands with Leber Congenital Amaurosis 2 (LCA2) and harboring mutations in RPE65.从携带 RPE65 突变的先天性黑蒙 2 型(LCA2)先证者中生成两个诱导多能干细胞系(LVPEIi004-A 和 LVPEIi005-A)。
Stem Cell Res. 2024 Jun;77:103413. doi: 10.1016/j.scr.2024.103413. Epub 2024 Apr 16.

引用本文的文献

1
Application of patient-derived induced pluripotent stem cells and organoids in inherited retinal diseases.诱导多能干细胞和类器官在遗传性视网膜疾病中的应用。
Stem Cell Res Ther. 2023 Nov 27;14(1):340. doi: 10.1186/s13287-023-03564-5.
2
Retinal Organoids from an AIPL1 CRISPR/Cas9 Knockout Cell Line Successfully Recapitulate the Molecular Features of LCA4 Disease.AIPL1 CRISPR/Cas9 基因敲除细胞系来源的视网膜类器官成功重现了 LCA4 疾病的分子特征。
Int J Mol Sci. 2023 Mar 21;24(6):5912. doi: 10.3390/ijms24065912.
3
Retinal Organoids derived from hiPSCs of an AIPL1-LCA Patient Maintain Cytoarchitecture despite Reduced levels of Mutant AIPL1.
源自 AIPL1-LCA 患者 hiPSC 的视网膜类器官在降低突变 AIPL1 水平的情况下仍保持细胞结构。
Sci Rep. 2020 Mar 25;10(1):5426. doi: 10.1038/s41598-020-62047-2.